![](/images/general/no_picture/200_user.png)
George Miller Jr
Examiner (ID: 13348)
Most Active Art Unit | 2106 |
Art Unit(s) | 2106, 2108, 2605, 3307, 2101, 2305 |
Total Applications | 1640 |
Issued Applications | 1557 |
Pending Applications | 1 |
Abandoned Applications | 82 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18877393
[patent_doc_number] => 20240000762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => TREATMENT REGIMENS FOR EARLY IDIOPATHIC PARKINSON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/370005
[patent_app_country] => US
[patent_app_date] => 2023-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18370005
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/370005 | TREATMENT REGIMENS FOR EARLY IDIOPATHIC PARKINSON'S DISEASE | Sep 18, 2023 | Pending |
Array
(
[id] => 18970335
[patent_doc_number] => 20240050427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => TREATMENTS FOR OBSESSIVE COMPULSIVE DISORDER
[patent_app_type] => utility
[patent_app_number] => 18/364827
[patent_app_country] => US
[patent_app_date] => 2023-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18364827
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/364827 | TREATMENTS FOR OBSESSIVE COMPULSIVE DISORDER | Aug 2, 2023 | Pending |
Array
(
[id] => 19210671
[patent_doc_number] => 11999719
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Solid form of compound
[patent_app_type] => utility
[patent_app_number] => 18/347335
[patent_app_country] => US
[patent_app_date] => 2023-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 39
[patent_no_of_words] => 10325
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18347335
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/347335 | Solid form of compound | Jul 4, 2023 | Issued |
Array
(
[id] => 18709090
[patent_doc_number] => 20230331681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 18/213055
[patent_app_country] => US
[patent_app_date] => 2023-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50770
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18213055
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/213055 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR | Jun 21, 2023 | Pending |
Array
(
[id] => 18270341
[patent_doc_number] => 20230091583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => READY TO USE, NORADRENALINE DRIP BAGS, HAVING LOW SUBVISIBLE PARTICLE COUNTS
[patent_app_type] => utility
[patent_app_number] => 17/991861
[patent_app_country] => US
[patent_app_date] => 2022-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9195
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17991861
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/991861 | READY TO USE, NORADRENALINE DRIP BAGS, HAVING LOW SUBVISIBLE PARTICLE COUNTS | Nov 21, 2022 | Pending |
Array
(
[id] => 18240081
[patent_doc_number] => 20230072392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => NASAL SPRAY
[patent_app_type] => utility
[patent_app_number] => 17/823275
[patent_app_country] => US
[patent_app_date] => 2022-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17823275
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/823275 | NASAL SPRAY | Aug 29, 2022 | Pending |
Array
(
[id] => 18109504
[patent_doc_number] => 20230002384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => TRICYCLIC HETEROCYCLES AS FGFR INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/835330
[patent_app_country] => US
[patent_app_date] => 2022-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17835330
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/835330 | TRICYCLIC HETEROCYCLES AS FGFR INHIBITORS | Jun 7, 2022 | Pending |
Array
(
[id] => 18056280
[patent_doc_number] => 20220387366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => Compositions for Regulating Homeostasis of Cortisol and Improving Sleep Quality and Methods of Use and Production Thereof
[patent_app_type] => utility
[patent_app_number] => 17/831862
[patent_app_country] => US
[patent_app_date] => 2022-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23688
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17831862
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/831862 | Compositions for Regulating Homeostasis of Cortisol and Improving Sleep Quality and Methods of Use and Production Thereof | Jun 2, 2022 | Pending |
Array
(
[id] => 17911286
[patent_doc_number] => 20220313681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF FOR THE TREATMENT OF VIRAL DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/742899
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21530
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 311
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17742899
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/742899 | NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF FOR THE TREATMENT OF VIRAL DISEASES | May 11, 2022 | Pending |
Array
(
[id] => 17988833
[patent_doc_number] => 20220354870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => READY-TO-USE BUPIVISONE PLUS LIQUID FORMULATION
[patent_app_type] => utility
[patent_app_number] => 17/720556
[patent_app_country] => US
[patent_app_date] => 2022-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11019
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17720556
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/720556 | READY-TO-USE BUPIVISONE PLUS LIQUID FORMULATION | Apr 13, 2022 | Pending |
Array
(
[id] => 17944275
[patent_doc_number] => 20220331292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => COMPOSITIONS AND METHODS FOR DELIVERY OF PSILOCIN AND PRODRUGS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/720501
[patent_app_country] => US
[patent_app_date] => 2022-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6784
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17720501
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/720501 | COMPOSITIONS AND METHODS FOR DELIVERY OF PSILOCIN AND PRODRUGS THEREOF | Apr 13, 2022 | Abandoned |
Array
(
[id] => 18673008
[patent_doc_number] => 20230310471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => METHODS, DEVICES, AND SYSTEMS FOR TREATING LENS PROTEIN AGGREGATION DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/718673
[patent_app_country] => US
[patent_app_date] => 2022-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17718673
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/718673 | METHODS, DEVICES, AND SYSTEMS FOR TREATING LENS PROTEIN AGGREGATION DISEASES | Apr 11, 2022 | Pending |
Array
(
[id] => 17959999
[patent_doc_number] => 20220340579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => PYRAZOLYL BICYCLIC AMINES AS CDK2 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/719131
[patent_app_country] => US
[patent_app_date] => 2022-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24299
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17719131
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/719131 | PYRAZOLYL BICYCLIC AMINES AS CDK2 INHIBITORS | Apr 11, 2022 | Pending |
Array
(
[id] => 17982559
[patent_doc_number] => 20220348595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ESTROGEN RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 17/716051
[patent_app_country] => US
[patent_app_date] => 2022-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17716051
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/716051 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ESTROGEN RECEPTORS | Apr 7, 2022 | Pending |
Array
(
[id] => 18264822
[patent_doc_number] => 20230086064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => CBL-B MODULATORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/658587
[patent_app_country] => US
[patent_app_date] => 2022-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 206794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17658587
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/658587 | CBL-B MODULATORS AND USES THEREOF | Apr 7, 2022 | Pending |
Array
(
[id] => 18672929
[patent_doc_number] => 20230310380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => METHODS, DEVICES, AND SYSTEMS FOR TREATING LENS PROTEIN AGGREGATION DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/713691
[patent_app_country] => US
[patent_app_date] => 2022-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10516
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17713691
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/713691 | METHODS, DEVICES, AND SYSTEMS FOR TREATING LENS PROTEIN AGGREGATION DISEASES | Apr 4, 2022 | Abandoned |
Array
(
[id] => 17896947
[patent_doc_number] => 20220306609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/701888
[patent_app_country] => US
[patent_app_date] => 2022-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17701888
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/701888 | BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS | Mar 22, 2022 | Pending |
Array
(
[id] => 17895338
[patent_doc_number] => 20220305000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => Combination Comprising Chloroquine, Metformin and Statin for Management of Cancer, Composition and Methods Thereof
[patent_app_type] => utility
[patent_app_number] => 17/701821
[patent_app_country] => US
[patent_app_date] => 2022-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15121
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17701821
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/701821 | Combination Comprising Chloroquine, Metformin and Statin for Management of Cancer, Composition and Methods Thereof | Mar 22, 2022 | Pending |
Array
(
[id] => 17928321
[patent_doc_number] => 20220323446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => SOTORASIB DOSING REGIMEN
[patent_app_type] => utility
[patent_app_number] => 17/696758
[patent_app_country] => US
[patent_app_date] => 2022-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20967
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17696758
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/696758 | SOTORASIB DOSING REGIMEN | Mar 15, 2022 | Pending |
Array
(
[id] => 17881084
[patent_doc_number] => 20220296561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => NON-ORAL MEDICATED CANNABINOID COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/693609
[patent_app_country] => US
[patent_app_date] => 2022-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15140
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17693609
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/693609 | NON-ORAL MEDICATED CANNABINOID COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT | Mar 13, 2022 | Abandoned |